前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里




查看所有供应商和价格请点击:

65002-17-7生产厂家

65002-17-7价格

65002-17-7

65002-17-7结构式
65002-17-7结构式
  • 常用中文名:布西拉明
  • 常用英文名:Bucillamine
  • CAS号:65002-17-7
  • 分子式:C7H13NO3S2
  • 分子量:223.313
  • 相关类别: 原料药 解热镇痛药 非甾抗炎药
  • 发布时间:2018-02-14 08:00:00
  • 更新时间:2024-01-02 19:37:43
  • 布西拉明(SA96)是一种口服活性和有效的巯基供体和抗氧化剂。布西拉明也是一种具有抗血管生成特性的抗风湿剂。布西拉明可以保护高危器官移植中的缺血/再灌注损伤。布西拉明抑制VEGF的产生。布西拉明可用于研究脉络膜新生血管(CNV)和类风湿性关节炎(RA)[1][2]。

化源商城直购

中文名 布溪那明
英文名 Bucillamine
中文别名 布西拉明
布西拉明
N-(2-巯基-2-甲基丙酰基)-L-半胱氨酸
N-(2-巯基-2-甲基-1-氧代丙基)-L-半胱氨酸
英文别名 L-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
Bucillamine
N-(2-Mercapto-2-methylpropionyl)-L-cysteine
(2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid
N-(2-Mercaptoisobutyryl)-L-cysteine
N-(2-Methyl-2-sulfanylpropanoyl)-L-cysteine
N-(2-Mercapto-2-methyl-1-oxopropyl)-L-cysteine
MFCD00867570
Thiobutarit
N-(2-Mercapto-2-methylpropanoyl)-L-cysteine
描述 布西拉明(SA96)是一种口服活性和有效的巯基供体和抗氧化剂。布西拉明也是一种具有抗血管生成特性的抗风湿剂。布西拉明可以保护高危器官移植中的缺血/再灌注损伤。布西拉明抑制VEGF的产生。布西拉明可用于研究脉络膜新生血管(CNV)和类风湿性关节炎(RA)[1][2]。
相关类别
体内研究 布西拉明显著提高接受肝移植的大鼠的存活率并保护其免受肝损伤[1]。布西拉明(结膜下注射)显著减少大鼠实验性CNV的渗漏和大小[2]。
参考文献

[1]. Amersi F, et al. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8915-20.

[2]. Yanagi Y, et al. Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat. Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3495-9.

密度 1.3±0.1 g/cm3
沸点 438.0±45.0 °C at 760 mmHg
熔点 119-123ºC
分子式 C7H13NO3S2
分子量 223.313
闪点 218.7±28.7 °C
精确质量 223.033676
PSA 144.00000
LogP 1.28
蒸汽压 0.0±2.3 mmHg at 25°C
折射率 1.553
储存条件 Hygroscopic, -20?C Freezer, Under Inert Atmosphere
分子结构

1、 摩尔折射率:55.38

2、 摩尔体积(cm3/mol):173.1

3、 等张比容(90.2K):461.6

4、 表面张力(dyne/cm):50.5

5、 极化率(10-24cm3):21.95

更多

1.性状:白色结晶或结晶性粉末,微臭。

2.熔点:139~140℃。

3.比旋光度:[α]D25+32.3°(C=1.0,乙醇)。

4.溶解度:易溶于甲醇、乙醇或冰醋酸,溶于氯仿、乙醚或乙酸乙酯,极微溶于水。

毒理学数据:

急性毒性LD50小鼠(mg/kg):2285腹腔注射,989.6静脉注射。急性毒性LD50雄、雌小鼠,雄、雌大鼠(mg/kg):4118,3892,4074,2961口服;1546, 1250,2165,2009皮下注射;1348,1501,1375,1035静脉注射。

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HA2420000
CHEMICAL NAME :
L-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
CAS REGISTRY NUMBER :
65002-17-7
LAST UPDATED :
199312
DATA ITEMS CITED :
18
MOLECULAR FORMULA :
C7-H13-N-O3-S2
MOLECULAR WEIGHT :
223.33
WISWESSER LINE NOTATION :
SHX1&1&VMYVQ1SH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3900 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
353 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1021 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1006 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4500 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
420 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1090 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - changes in motor activity (specific assay) Lungs, Thorax, or Respiration - cyanosis
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
990 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4305958
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - respiratory stimulation Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 29,429,1985 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
18200 mg/kg/52W-C
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic - changes in metals, not otherwise specified
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 19,429,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
15 gm/kg/30D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes in urine composition Kidney, Ureter, Bladder - changes in bladder weight Blood - other changes
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45500 mg/kg/91D-I
TOXIC EFFECTS :
Blood - changes in erythrocyte (RBC) count Kidney, Ureter, Bladder - changes in bladder weight Related to Chronic Data - changes in testicular weight
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 14,346,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
18 gm/kg/15W-I
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic - changes in metals, not otherwise specified
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 29,429,1985 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4800 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - other measures of fertility Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,626,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1200 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,626,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3600 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,626,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
840 mg/kg
SEX/DURATION :
female 15-21 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,665,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3900 mg/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970- Volume(issue)/page/year: 16,654,1985

危害码 (欧洲) T,N,Xi
风险声明 (欧洲) R23/24/25:Toxic by inhalation, in contact with skin and if swallowed . R50/53:Very Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment .
安全声明 (欧洲) S26-S27-S28-S45-S60-S61
危险品运输编码 UN 3146 6.1/PG 3
WGK德国 3
包装等级 III
危险类别 6.1
海关编码 2930909090
上游产品  3

下游产品  1

S-苄基-2-巯基-2-甲基丙酸(63.1g,0.30mo1)和氯化亚砜(39.3g, 0.33mo1)反应,得S-苄基-2-巯基-2-甲基丙酰氯。另外将S-苄基-L-半胱氨酸(73.9g,0.35mo1)溶于lmol/L氢氧化钠溶液(700ml,0.70mo1),用冰浴冷却,在搅拌下滴入上述得到的丙酰氯衍生物,加毕再搅拌1h。用盐酸酸化后,用乙酸乙酯提取。提取液水洗后,无水硫酸钠干燥,浓缩。剩余物用硅胶柱层析,用苯-乙酸乙酯(1:1)洗脱。洗脱液减压蒸发至于,得89.6g的油状物,收率74%。
将上述得到的油状物(89.6g,0.222mol)溶于500ml液氨,在搅拌下,分批小量加入金属钠(21.2g,0.917mo1)。当反应完全后,加入氯化铵(59.4g,1.11mo1),蒸出氨。剩余物加水溶解。分出水层,用乙酸乙酯洗,然后在冷却下用盐酸酸化。用乙酸乙酯提取酸化产生的沉淀。提取液用水洗,无水硫酸钠干燥,减压浓缩,乙酸乙酯重结晶,得40.1g布西拉明,收率81%,熔点139~140℃。65002-17-7 preparation

海关编码 2930909090
中文概述 2930909090. 其他有机硫化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%
申报要素 品名, 成分含量, 用途
Summary 2930909090. other organo-sulphur compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%